Healthcare Discoveries Inc. Report issue

For profit Phase 1 Phase 2
Founded: San Antonio TX United States (1993)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2006
NCT00330083
First Marketed Drug
1993
atenolol (tenormin)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Healthcare Discoveries, Inc. | Healthcare Discoveries LLC | Healthcare Discoveries, LLC/ICON | Healthcare Discoveries LLC Icon Development Solutions | HLTHCARE

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 1)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 1)

Diabetes Mellitus, Type 2 (Phase 2)

Duodenal Ulcer (Phase 1)

Esophagitis (Phase 1)

Gastroesophageal Reflux (Phase 1)

Hypersensitivity (Phase 1)

Infarction (Phase 1)

Influenza, Human (Phase 2)

Ischemia (Phase 1)

Myocardial Infarction (Phase 1)

Myocardial Ischemia (Phase 1)

Osteoporosis (Phase 1)

Stomach Ulcer (Phase 1)

Ulcer (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 10
  • # of Trial APIs: 7